R3i leads new research into atherogenic dyslipidemia in type 2 diabetes
型糖尿病中的动脉粥状硬化新研究。
Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with type 2 diabetes and additional atherogenic risk factors .
对有二型糖尿病及其他导致动脉粥样化风险因素的冠心病无症状患者筛查的成本－效果。
Atherogenic dyslipidemia is common and the prevalence is markedly increasing as a result of the global epidemic of type 2 diabetes , obesity and metabolic syndrome .
粥状动脉硬化很常见并且越来越普遍，因为2型糖尿病，肥胖和代谢侯症成为国际性通病。
Currently , we are conducting the first world-wide epidemiological study , realist , to establish the prevalence of atherogenic dyslipidemia and consequent residual risk of cardiovascular events .
